Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Vogt

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of the Pediatric Infectious Diseases Society|December 28, 2018
Current Understanding of Humoral Immunity to Enterovirus D68Matthew R Vogt, James E Crowe
Cell Host & Microbe|September 15, 2022
A counterintuitive antibody cocktail disrupts coxsackievirusSeth J Zost, Matthew R Vogt
Journal of Virology|March 25, 2025
<i>Parechovirus</i>: neglected for too long?Fahmida Alam, You Li, Matthew R Vogt
Mbio|November 1, 2023
An unexpected, pH-sensitive step of the enterovirus D68 lifecycleDavid Aponte-Diaz, Matthew R Vogt, Craig E Cameron
Journal of Virology|May 6, 2011
Beta interferon controls West Nile virus infection and pathogenesis in miceHelen M Lazear, Amelia K Pinto, Matthew R Vogt, et al.
Iscience|July 29, 2025
Respiratory infection with Enterovirus D68 induces severe acute lung inflammation in the pediatric ferret modelCassandra S Grizer, Kenneth C Elliott, Garima Singh, et al.
Journal of Virology|July 1, 2026
ATG9A is an essential host factor for parechovirus RNA replicationYou Li, Lorellin A Durnell-Bettis, Fahmida Alam, et al.
Journal of Virology|September 16, 2011
Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanismsMatthew R Vogt, Kimberly A Dowd, Michael Engle, et al.
The Journal of Infectious Diseases|June 17, 2009
Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virusShuliu Zhang, Matthew R Vogt, Theodore Oliphant, et al.
Virology Journal|May 14, 2010
Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in miceMatthew D Dunn, Shannan L Rossi, Donald M Carter, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of the Pediatric Infectious Diseases Society|December 28, 2018
Current Understanding of Humoral Immunity to Enterovirus D68Matthew R Vogt, James E Crowe
Cell Host & Microbe|September 15, 2022
A counterintuitive antibody cocktail disrupts coxsackievirusSeth J Zost, Matthew R Vogt
Journal of Virology|March 25, 2025
<i>Parechovirus</i>: neglected for too long?Fahmida Alam, You Li, Matthew R Vogt
Mbio|November 1, 2023
An unexpected, pH-sensitive step of the enterovirus D68 lifecycleDavid Aponte-Diaz, Matthew R Vogt, Craig E Cameron
Journal of Virology|May 6, 2011
Beta interferon controls West Nile virus infection and pathogenesis in miceHelen M Lazear, Amelia K Pinto, Matthew R Vogt, et al.
Iscience|July 29, 2025
Respiratory infection with Enterovirus D68 induces severe acute lung inflammation in the pediatric ferret modelCassandra S Grizer, Kenneth C Elliott, Garima Singh, et al.
Journal of Virology|July 1, 2026
ATG9A is an essential host factor for parechovirus RNA replicationYou Li, Lorellin A Durnell-Bettis, Fahmida Alam, et al.
Journal of Virology|September 16, 2011
Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanismsMatthew R Vogt, Kimberly A Dowd, Michael Engle, et al.
The Journal of Infectious Diseases|June 17, 2009
Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virusShuliu Zhang, Matthew R Vogt, Theodore Oliphant, et al.
Virology Journal|May 14, 2010
Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in miceMatthew D Dunn, Shannan L Rossi, Donald M Carter, et al.
Pageof 2